Panion & Bf Biotech Inc. (1760.TW)
- Previous Close
73.80 - Open
73.80 - Bid 74.80 x --
- Ask 75.10 x --
- Day's Range
73.80 - 75.60 - 52 Week Range
56.00 - 104.50 - Volume
174,299 - Avg. Volume
157,865 - Market Cap (intraday)
6.422B - Beta (5Y Monthly) --
- PE Ratio (TTM)
58.98 - EPS (TTM)
1.27 - Earnings Date Aug 11, 2025 - Aug 15, 2025
- Forward Dividend & Yield 1.50 (2.03%)
- Ex-Dividend Date Jun 13, 2024
- 1y Target Est
--
Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, and health care products in Taiwan, the United States, China, Hong Kong, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, Covid-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygiene services. Panion & Bf Biotech Inc. was founded in 1974 and is headquartered in Taipei, Taiwan.
www.pbf.com.twRecent News: 1760.TW
View MorePerformance Overview: 1760.TW
Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1760.TW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1760.TW
View MoreValuation Measures
Market Cap
6.33B
Enterprise Value
6.50B
Trailing P/E
58.11
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.15
Price/Book (mrq)
3.52
Enterprise Value/Revenue
3.23
Enterprise Value/EBITDA
17.51
Financial Highlights
Profitability and Income Statement
Profit Margin
5.41%
Return on Assets (ttm)
4.07%
Return on Equity (ttm)
6.00%
Revenue (ttm)
2.01B
Net Income Avi to Common (ttm)
108.86M
Diluted EPS (ttm)
1.27
Balance Sheet and Cash Flow
Total Cash (mrq)
505.08M
Total Debt/Equity (mrq)
38.72%
Levered Free Cash Flow (ttm)
159.13M